written on 24.03.2014

Politicians add fuel to the firestorm over Gilead's hep C drug pricing


Rep. Henry Waxman and several Democratic colleagues in Congress wrote Gilead CEO John Martin an excoriating letter on Friday, demanding to know why Gilead Sciences' hepatitis C wonder drug Sovaldi costs $84,000–and whether Gilead is doing anything to make sure that poor patients get access to it.